Neogen

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety and Animal Safety. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Neogen reports robust Q2 earnings, targets $1B revenue by 2025

Neogen's Q2 2023 earnings call highlighted impressive revenue growth, improved margins, and strategic focus on integration and customer service.
While facing challenges related to increased debt levels and operational complexities, Neogen aims for ambitious revenue and EBITDA targets by 2025.
The company's performance underscores its potential for continued success in the Food Safety and Animal Safety segments through organic growth and financial discipline.

Neogen reports robust Q3 earnings, focuses on data analytics growth

Neogen's Q3 performance reflects strong revenue growth and strategic focus on data analytics for food security. While challenges exist in certain business segments, the company remains optimistic about long-term opportunities and integration synergies.

Neogen reports stellar Q4 results, eyes growth through integration

Neogen's Q4 2023 earnings call highlighted robust financial performance, successful integration of acquired divisions, and strategic outlook for fiscal '24. The company's focus on growth, innovation, and market expansion positions it well for continued success in the food safety and animal health sectors.

Neogen reports robust Q1 earnings, eyes growth amid regional challenges

Neogen's Q1 2024 showed strong revenue growth but faced challenges in core revenue.
The company highlighted progress in key segments like Food Safety and genomics.
Efficiency issues from ERP implementation impacted revenue timing.
Management remains optimistic about the full-year outlook despite regional challenges.

Neogen reports flat Q2 revenues, focuses on integration and market challenges

Neogen's Q2 performance was mixed, with strengths in certain segments and challenges in others. The company remains optimistic about its long-term prospects despite market headwinds.

Neogen reports improved margins in Q3 despite integration challenges

Neogen's Q3 2024 performance showed improvements in gross margin and EBITDA, but challenges with shipping inefficiencies and integration impacted revenue growth. The company is focused on resolving operational inefficiencies and regaining lost customers to achieve long-term growth goals.

Neogen reports Q4 revenue growth but faces EBITDA margin decline

Neogen's Q4 showed mixed performance with revenue growth but declining EBITDA margins.
The company faces challenges in the soft food safety end market and supply constraints.
However, Neogen is focusing on innovation and underpenetrated markets for future growth.

Neogen reports Q1 revenue decline, focuses on food safety growth

Neogen's Q1 performance showed mixed results with revenue decline and EBITDA pressure.
The company's strengths lie in its strategic positioning in food safety and customer-focused approach.
Challenges persist in certain segments, requiring operational adjustments for sustained growth.
Identified opportunities in geographic expansion and strategic investments can drive future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

LEXINGTON, Ky. , Jan. 15, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that it has launched the Provecta® Pro Flea & Tick Collar for Dogs**.

Neogen® Releases Provecta® Pro Flea & Tick Collar for Dogs**

Neogen's (NEOG) Q2 revenues decline year over year due to lower Animal Safety business.

Neogen's (NEOG) Q2 Earnings Miss Estimates, 2024 View Down

The headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended November 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Neogen (NEOG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Neogen Corporation (NEOG) Q2 2024 Earnings Call Transcript

Revenue of $229.6 million. Net loss of $3.5 million; $(0.02) per diluted share.

Neogen Announces Second-Quarter 2024 Results

Haemonetics

Prestige Brands Holdings

Royal Philips

Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. PHG, NEOG, HAE and PBH are well-poised to gain from the favorable factors.

4 Medical Product Stocks to Buy Amid Industry Challenges

LANSING, Mich. , Dec. 21, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 42nd Annual J.P.

Neogen to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

LANSING, Mich. , Dec. 19, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) will issue its second-quarter earnings release before the opening of the market on Tuesday, January 9, 2024.

Neogen Announces Second-Quarter Earnings Release Date

Neogen's (NEOG) strategic alliance will expand feline DNA testing and strengthen its relationship with the kitty community.

Neogen (NEOG) to Advance Feline DNA Testing With New Pact

Investors are optimistic about Neogen (NEOG), owing to product launches and the performance of segments.

Here's Why You Should Buy Neogen (NEOG) Stock Now

LINCOLN, Neb. , Dec. 14, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it is collaborating with the Cat Fanciers' Association (CFA), a leading authority in feline advocacy.

Neogen®, Cat Fanciers' Association Collaborate to Advance Feline DNA Testing

Neogen will be able to highlight its biosecurity and horse health products, like the COMPANION range of cleansers and disinfection solutions, through the latest collaboration.

Neogen (NEOG) to Offer Biosecurity Products With New Pact

LEXINGTON, Ky. , Dec. 5, 2023 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that it has partnered with the TerraNova Equestrian Center in Myakka City, Florida, making the company the official biosecurity provider of the facility.

Neogen® Announces Biosecurity Partnership with TerraNova

Neogen's (NEOG) Veratox VIP for Walnut allergy test displays robust performance across sample types while keeping the Veratox product line's simple testing approach.

Neogen (NEOG) Unveils New Assay for Walnut Allergens Detection

LANSING, Mich. , Nov. 30, 2023 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that it has released its innovative Veratox® VIP assay for the detection of walnut, the third assay in Neogen's Veratox VIP line of enhanced quantitative ELISA products.

Neogen® Launches Highly Sensitive Quantitative ELISA Assay for the Detection of Walnut Allergens

LANSING, Mich. , Nov. 21, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on Thursday, November 30, 2023.

Neogen® to Participate in the Piper Sandler 35th Annual Healthcare Conference

Neogen (NEOG) is progressing well in terms of picking the right growth markets and gaining a bigger share of those markets.

Neogen's (NEOG) Innovation Aids, Currency Headwind Stays

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?

Neogen (NEOG) Up 3.6% Since Last Earnings Report: Can It Continue?

Neogen's weak first quarter results, including flat revenue on a pro forma basis, have seriously damaged its growth stock reputation, leading to a major decline in the shares. The integration of 3M's Food Safety business has faced multiple challenges, and it will take time to fully maximize the earnings power of this combined business. Getting all the acquired business operations under a Neogen-controlled roof should be a big help, but is still a year out.

Neogen Struggling Through An Awkward Transition

Neogen's (NEOG) Q1 Animal Safety business experiences continued destocking, with channel inventory levels reaching multi-year lows.

Neogen's (NEOG) Q1 Earnings Miss Estimates, Margins Rise

While the top- and bottom-line numbers for Neogen (NEOG) give a sense of how the business performed in the quarter ended August 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Neogen (NEOG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Neogen (NEOG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Here's Why Neogen (NEOG) is Poised for a Turnaround After Losing -14.43% in 4 Weeks

Neogen Corporation (NASDAQ:NEOG ) Q1 2024 Earnings Call Transcript October 10, 2023 8:00 AM ET Company Participants Bill Waelke - Head, Investor Relations John Adent - Chief Executive Officer David Naemura - Chief Financial Officer Conference Call Participants Brandon Vazquez - William Blair Timothy Daley - Wells Fargo Operator Welcome to the Neogen Corporation First Quarter 2024 Earnings Call. All participants will be in listen-only mode.

Neogen Corporation (NEOG) Q1 2024 Earnings Call Transcript

Neogen (NEOG) came out with quarterly earnings of $0.11 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.15 per share a year ago.

Neogen (NEOG) Lags Q1 Earnings and Revenue Estimates

Neogen Corporation (NASDAQ:NEOG) shares fell ahead of the opening bell on Tuesday after the specialist in food safety solutions reported a rise in first-quarter revenue but a decline in earnings, with both measures missing analysts' forecasts. The company, which acquired 3M's former food-safety division a year ago posted a 73% rise in revenue rose to $229 million, falling short of the $231.8 million consensus forecast of three analysts surveyed by Zacks Investment Research.

News for Neogen Stock (NEOG)